Originally posted on June 24, 2002
In this commentary, Alex Tabarrok of George Mason comments on an idea to introduce innovation and reduce the cost of drugs. Pulling from a paper by Michael Kremer, he outlines the reasoning behind patent buyouts and how they could be used effectively to help put good ideas in the hands of the public.
Related Content: